Areas of Expertise

Corporate & Advisory, Equity & Debt Capital Markets, Mergers & Acquisitions; Corporate Governance

Emma's key areas of focus are equity and debt capital markets, mergers and acquisitions, private equity and corporate advisory. She provides clients with access to high-level skills in areas that are heavily regulated and highly technical.

Emma has a particular expertise advising clients in the health, life sciences, biotechnology, technology, agriculture, infrastructure, retail and manufacturing sectors.

Emma's practice includes a cross-border component with an Asia-focus and she has expertise in capital markets and M&A transactions involving clients in Hong Kong, Singapore, the People’s Republic of China and Indonesia.

What others say

“Emma and the Thomson Geer team are the most pragmatic legal firm I have worked with over my career. They operate with a client first mindset to reliably deliver fast and practical outcomes. Couldn’t recommend Emma and her team enough.”
Luke Reid - CEO of Microba Life Science Limited
"I trust and value highly the advice of TG team members, including Emma Cook…They have a high level of integrity, are dedicated to providing protection for our company, and always work towards effective outcomes."
Legal 500 Asia-Pacific
"Key Lawyer – Australia, Corporate M&A"
Legal 500 Asia-Pacific
"Emma’s unwavering commitment to her clients and getting the deal done through quite long negotiations was not only admirable but she went above and beyond in terms of her availability and quick turn around times. Emma’s calm but persistent approach to negotiations enabled positive outcomes to be achieved where others may not have had success. She is the most responsive and technically astute lawyer I have instructed in my 25+ year legal career. I highly recommend her."
Annabelle Simon, General Counsel, Simon Transport

Experience

IPOs

Advising on the IPO and ASX listing of numerous organisations, both domestic and offshore (including Microba Life Sciences Ltd (ASX:MAP), Biome Ltd (ASX:BIO) East 33 Ltd (ASX:E33), Terragen Holdings Ltd (ASX:TGH), Axsesstoday Ltd (ASX:AXL), Fintech Chain Ltd (ASX:FTC), 99Wuxian Ltd (ASX:NNW), eCargo Holdings Ltd (ASX:ECG), Retech Technology Co., Ltd (ASX:RTE) and Macarthur Australia Ltd (ASX:MIO).

Schemes of arrangement

Advising both target and bidders in regulated schemes of arrangements (transfer & cancellation schemes) - including advising on the redomiciliation of Embark Early Group Ltd from the NZX to the ASX and the redomiciliation scheme of arrangement to Embark Early Education Ltd and the on-market takeover bid of Altamin Ltd by V B S Exchange Pty Ltd.

Backdoor listings

Advising on the backdoor listing on the ASX of numerous organisations, acting for both the listed entity and the target entity (including SenSen Networks Ltd (ASX:SNS) and Bubs Australia Ltd (ASX: BUB).

Secondary market raisings

Advising on secondary market equity raisings on the ASX and NSX including share purchase plans, accelerated and traditional entitlement offers and share placements. This includes the 19.99% share placement in Microba Life Sciences Ltd by Sonic Healthcare Group Ltd.

Advising brokers

Advising brokers on underwriting and lead manager arrangements for initial public offerings and secondary market equity raisings. Such brokers and lead managers include Bell Potter Securities, Morgans Corporate Ltd and Canaccord Genuity (Australia) Ltd.